Gilotrif 30 mg/1

Gilotrif 30 mg is a targeted therapy used to treat specific types of cancer. This oral medication, containing afatinib, is designed to inhibit certain proteins involved in cancer cell growth.

Gilotrif 30 mg is primarily used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic markers. It works by targeting and blocking the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gilotrif used for?' This medication is typically prescribed for advanced or metastatic NSCLC where other treatments may not be effective.

Common effects of Gilotrif 30 mg may include skin rash, diarrhea, and fatigue. Some patients may also experience nausea, loss of appetite, or mouth sores. These effects can vary in severity and may require management under medical supervision.

Gilotrif 30 mg should be handled with care, following the prescribed dosage and administration guidelines. It is important to inform healthcare providers about any pre-existing conditions, especially lung or heart issues. Regular monitoring may be necessary to manage potential side effects effectively.

Gilotrif 30 mg may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid grapefruit products, as they can alter the medication's effectiveness. Always consult a healthcare provider before starting or stopping any other medications while taking Gilotrif.